COVID-19 vaccines: Frequently asked questions and updated answers

At the end of December 2019, China notified the World Health Organization about a viral pneumonia epidemic soon to be named COVID-19, of which the infectious agent, SARS-CoV-2, was rapidly identified. Less than one year later, published phase 3 clinical trials underlined the effectiveness of vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lefebvre, M., Vignier, N., Pitard, B., Botelho-Nevers, E., Wyplosz, B., Cohen, R., Epaulard, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910656/
https://www.ncbi.nlm.nih.gov/pubmed/33681861
http://dx.doi.org/10.1016/j.idnow.2021.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910656/
https://www.ncbi.nlm.nih.gov/pubmed/33681861
http://dx.doi.org/10.1016/j.idnow.2021.02.007

Ejemplares similares